DK0397113T3 - Fremgangsmåde til påvisning af specifikt bindingsdygtige stoffer i legemsvæsker - Google Patents

Fremgangsmåde til påvisning af specifikt bindingsdygtige stoffer i legemsvæsker

Info

Publication number
DK0397113T3
DK0397113T3 DK90108656.1T DK90108656T DK0397113T3 DK 0397113 T3 DK0397113 T3 DK 0397113T3 DK 90108656 T DK90108656 T DK 90108656T DK 0397113 T3 DK0397113 T3 DK 0397113T3
Authority
DK
Denmark
Prior art keywords
ligand
coating
body fluids
specific binding
binding substances
Prior art date
Application number
DK90108656.1T
Other languages
English (en)
Inventor
Hnle Beatus Dr Rer Ofenloch-H
Michael Dr Rer Nat Berger
Arno Dr Rer Nat Deger
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of DK0397113T3 publication Critical patent/DK0397113T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DK90108656.1T 1989-05-09 1990-05-08 Fremgangsmåde til påvisning af specifikt bindingsdygtige stoffer i legemsvæsker DK0397113T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3915135A DE3915135A1 (de) 1989-05-09 1989-05-09 Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten

Publications (1)

Publication Number Publication Date
DK0397113T3 true DK0397113T3 (da) 1994-02-07

Family

ID=6380321

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90108656.1T DK0397113T3 (da) 1989-05-09 1990-05-08 Fremgangsmåde til påvisning af specifikt bindingsdygtige stoffer i legemsvæsker

Country Status (7)

Country Link
US (1) US5212063A (da)
EP (1) EP0397113B1 (da)
JP (1) JPH07117536B2 (da)
AT (1) ATE97496T1 (da)
DE (2) DE3915135A1 (da)
DK (1) DK0397113T3 (da)
ES (1) ES2047749T3 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184386C (en) * 1994-03-05 2005-10-18 Rosemarie Kientsch-Engel Interference eliminating agent for application in immunoassays
WO1997006439A1 (en) 1995-08-09 1997-02-20 Quidel Corporation Test strip and method for one step lateral flow assay
ES2127691B1 (es) * 1996-10-21 2000-04-01 Biolatex S L Procedimiento de union covalente de ligandos para la preparacion de r eactivos inmunoquimicos para utilizacion en inmunoanalisis homogeneos que emplean microparticulas (mps) y su aplicacion a la medida de ferritina y del receptor soluble de la transferrina en suero o plasma sangu
JPH10246725A (ja) * 1997-03-03 1998-09-14 Mikio Nakayama 抗体又は抗原の検出方法
US5958704A (en) * 1997-03-12 1999-09-28 Ddx, Inc. Sensing system for specific substance and molecule detection
DE19724787A1 (de) * 1997-06-06 1998-12-10 Biotez Berlin Buch Gmbh Bioche Streptavidin/Avidin beschichtete Oberflächen
US6410692B2 (en) * 1998-02-02 2002-06-25 Novadx, Inc. Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix
US6303325B1 (en) * 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
US6143507A (en) * 1998-10-29 2000-11-07 Boehringer Ingelheim Pharmaceuticals, Inc. High throughput compatible assay for receptor-TRAF interactions
EP1215496A4 (en) * 1999-09-13 2005-06-08 Nissui Pharm Co Ltd METHOD AND KIT FOR DETECTING OR DETERMINING A SUBSTANCE
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
EP1184666A3 (en) * 2000-08-21 2002-04-10 Roche Diagnostics GmbH Auxiliary haptens and haptenylated agents in displacement immunoassays
AU2002241602A1 (en) * 2000-11-16 2002-06-11 Burstein Technologies, Inc. Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
CA2446246A1 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
JP4839530B2 (ja) * 2001-06-08 2011-12-21 東ソー株式会社 測定妨害を低減する方法及び試薬組成物
US20030143637A1 (en) * 2001-08-31 2003-07-31 Selvan Gowri Pyapali Capture layer assemblies for cellular assays including related optical analysis discs and methods
CN1659439A (zh) * 2001-09-07 2005-08-24 伯斯坦技术公司 利用光学生物盘系统基于细胞核形态学的白血细胞类型的识别和定量
CA2468041A1 (en) * 2001-11-20 2003-05-30 Burstein Technologies, Inc. Optical bio-discs and microfluidic devices for analysis of cells
US7108993B2 (en) * 2002-07-19 2006-09-19 Bayer Healthcare Llc Use of dual conjugated labels in the elimination of serum interference in immunochromatographic assays
US20050112586A1 (en) 2003-11-24 2005-05-26 Roland Janzen Method and composition for stabilizing liquid reagents
US20060046310A1 (en) * 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
EP2541250A1 (en) * 2011-06-30 2013-01-02 Koninklijke Philips Electronics N.V. Molecular architecture on magnetic particles for affinity assays with low non-specific binding
BR112018001956A2 (pt) 2015-08-20 2018-09-11 Hoffmann La Roche ?método de medição de analitos e kit?
WO2018141768A1 (en) 2017-02-02 2018-08-09 Roche Diagnostics Gmbh Immunoassay using at least two pegylated analyte-specific binding agents
EP3791167A1 (en) 2018-05-07 2021-03-17 Immundiagnostik AG System for analysing quantitative lateral flow chromatography
WO2020023899A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Methods for depletion and enrichment
ES2942134T3 (es) 2018-09-25 2023-05-30 Siemens Healthcare Diagnostics Inc Composiciones, kits y métodos para ensayos multiplex para corregir la interferencia de biotina en mediciones de analitos diana
US11313855B2 (en) * 2018-09-25 2022-04-26 Siemens Healthcare Diagnostics Inc. Methods and compositions for removing biotin interference from assays using conjugated molecular traps
EP4325221B1 (en) 2018-09-25 2025-10-29 Siemens Healthcare Diagnostics Inc. Molecular trap for removing fluorescein interference from assays
CN112703400B (zh) * 2018-09-25 2024-10-15 美国西门子医学诊断股份有限公司 用于从使用环糊精阱的测定除去生物素干扰的方法和组合物
WO2020068609A1 (en) 2018-09-28 2020-04-02 Siemens Healthcare Diagnostics Inc. Compositions and methods for removing interfering substances
CN111122851A (zh) * 2018-10-31 2020-05-08 博阳生物科技（上海）有限公司 一种抗干扰剂的制备方法及由此方法制备的抗干扰剂的应用
CN111122842A (zh) * 2018-10-31 2020-05-08 博阳生物科技（上海）有限公司 一种抗干扰剂及其应用
CN111122845A (zh) * 2018-10-31 2020-05-08 博阳生物科技（上海）有限公司 一种抗生物素干扰的化学发光免疫分析试剂盒及其应用
WO2020165456A1 (en) 2019-02-15 2020-08-20 Immundiagnostik Ag Rapid test for diagnosis of bacterial infections in neonates
CN112129933B (zh) * 2019-06-25 2024-01-05 迈克生物股份有限公司 一种免疫分析系统中抗生物素干扰的试剂、试剂盒及方法
CN118401839A (zh) 2021-12-17 2024-07-26 美国西门子医学诊断股份有限公司 生物素捕获珠及其生产方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease
US4282287A (en) * 1980-01-24 1981-08-04 Giese Roger W Biochemical avidin-biotin multiple-layer system
US4550075A (en) * 1983-06-22 1985-10-29 Kallestad Laboratories, Inc. Method for ligand determination utilizing an immunoassay monitorable by biotin-containing enzymes, and compositions therefor
US4582810A (en) * 1983-09-30 1986-04-15 Becton, Dickinson And Company Immuno-agglutination particle suspensions
US4752638A (en) * 1983-11-10 1988-06-21 Genetic Systems Corporation Synthesis and use of polymers containing integral binding-pair members
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
DE3640412A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
DE3720983A1 (de) * 1987-06-25 1989-01-05 Hoechst Ag Immunometrisches bestimmungsverfahren
FR2624613B1 (fr) * 1987-12-15 1994-08-26 Toledano Jacques Support microspherique de detection immuno-enzymatique, fluorescente, cheminumilescente ou radio-active de substances microdosees dans les milieux biologiques
EP0353895A1 (en) * 1988-07-18 1990-02-07 MITSUI TOATSU CHEMICALS, Inc. Immunoassay method
DE3829245A1 (de) * 1988-08-29 1990-03-01 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
US5212063A (en) 1993-05-18
JPH02309254A (ja) 1990-12-25
EP0397113A2 (de) 1990-11-14
ES2047749T3 (es) 1994-03-01
DE59003503D1 (de) 1993-12-23
ATE97496T1 (de) 1993-12-15
JPH07117536B2 (ja) 1995-12-18
EP0397113B1 (de) 1993-11-18
DE3915135A1 (de) 1990-11-15
EP0397113A3 (de) 1991-05-29

Similar Documents

Publication Publication Date Title
EP0397113A3 (de) Verfahren zum Nachweis spezifisch bindefähiger Substanzen in Körperflüssigkeiten
EP0303110B1 (en) Immunodiagnostic device and method
AU616782B2 (en) Carrier matrix with dissolvably impregnated reagent
WO1984004171A1 (en) Detection of human chorionic gonadotropin
CA2330100A1 (en) Ligand binding assay and kit with a separation zone for disturbing analytes
TW594010B (en) Internal calibration system for flow-through assays
KR890002227A (ko) 특이적으로 결합가능한 단백질 물질의 측정 방법
ATE202213T1 (de) Schnellnachweis von analyten mit auf löslichen submikron-teilchen immobilisierten rezeptoren
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
JPS57200862A (en) Mutilayer analysis element utilizing unique binding reaction
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
ES2001447A6 (es) Un dispositivo de ensayo para determinar el tipo de sangre de una muestra de sangre
KR920008487A (ko) 신속한 1회 수동분석을 실시하기 위한 장치
KR920001202A (ko) 카복시-함유 중합체로부터 제조된 생물학적 활성을 갖는 시약, 이를 함유하는 분석 요소 및 이의 사용방법
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
US4317810A (en) Waffle-like matrix for immunoassay and preparation thereof
EP1318401A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
IL66289A0 (en) Preparation of analytical element for specific binding assays
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
KR910001379A (ko) 핵산 결정 방법
JPS63210664A (ja) 酸素要求検出系を用いる装置のための乾燥試験片及び被検流体中の分析成分の検出方法
JPS57196153A (en) Analysis element
CA2213083A1 (en) Detection of antibody production
DE3577478D1 (de) Verfahren zur konzentrierung und bestimmung von biomolekuelen und zellen.